Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Enjoy your FREE PREVIEW which shows only 2022 data and 25 documents. Contact Patent Forecast for full access.        


Read More News and Insights

Complex Cannabinoid Mixtures for Treating Neurodegenerative Diseases

Z-ARCHIVE-Cannabis Patent Forecast®

May 21, 2020

GBS Global BioPharma Inc. of Ontario, Canada received a patent (US Pat. No. 10,653,640) this week for a complex cannabinoid mixture for treating neurodegenerative diseases like Alzheimer's and Parkinson’s disease.

A main cannabinoid (CBD or CBN) is mixed with a minor cannabinoid (cannabichromene, cannabigerol, and cannabidivarin) and terpenes (limonene, linalool, nerolidol, pinene, and phytol) along with a pharmaceutically acceptable carrier. 

Cannabinoids can target mechanistic pathways of Parkinson’s disease as well as have beneficial effects on the mitochondria by acting as an antioxidant and decreasing oxidative stress.

The therapeutic benefits of cannabinoids are still being studied and harnessed. Take a look at patents and patent applications for cannabinoid supplements and medications with a subscription to Magic Number’s Cannabis Patent Forecast®

selective focus photography of person holding drop bottle

Relevant Patent Documents

Patent US10653640  

Read more like this in News This Week!   or   Share this link with your connections!